三生制药(01530)近日发布了补充公告,就公司股份奖励计划的最新进展进行了详细说明。公告中指出,娄竞博士作为承授人之一,因在此次奖励中持有重大利益,特在董事会审议相关授出事项时主动放弃了投票权,以确保决策的公正性。此次补充公告进一步明确了奖励计划的执行细节,强调这是为了增强透明度及符合相关法规要求。公告同时确认,除补充披露的信息外,之前公告中的所有资料与内容均维持不变,保持了信息的连续性和准确性...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.